Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
- 31 March 2005
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 149 (3), 464-473
- https://doi.org/10.1016/j.ahj.2004.11.023
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaThe American Journal of Cardiology, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesThe New England Journal of Medicine, 2004
- Population implications of changes in lipid management in patients with coronary heart disease.The American Journal of Cardiology, 2004
- Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive proteinThe American Journal of Cardiology, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988